Literature DB >> 20978592

Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.

E Otten1, R H Lekanne Dit Deprez, M M Weiss, M van Slegtenhorst, M Joosten, J J van der Smagt, N de Jonge, W S Kerstjens-Frederikse, M T R Roofthooft, A H M M Balk, M P van den Berg, J S Ruiter, J P van Tintelen.   

Abstract

Background. About 30% of dilated cardiomyopathy (DCM) cases are familial. Mutations are mostly found in the genes encoding lamin A/C, beta-myosin heavy chain and the sarcomeric protein cardiac troponin-T (TNNT2). Mutations in TNNT2 are reported in approximately 3% of DCM patients. The overall phenotype caused by TNNT2 mutations is thought to be a fully penetrant, severe disease. This also seems to be true for a recurrent deletion in the TNNT2 gene; p.K217del (also known as p.K210del). Methods. We compared the phenotype of all Dutch patients identified as carrying the TNNT2 p.K217del mutation with those described in the literature. All index patients underwent cardiological evaluation. Family screening was done in all described families. Results. Six DCM patients carrying the TNNT2 p.K217del mutation were identified from four Dutch families. Mean age of disease manifestation was 33 years. Heart transplantation was required in three of them at ages 12, 18 and 19 years. These outcomes are comparable with those described in the literature. Conclusion. Carriers of the TNNT2 p.K217del mutation in our Dutch families, as well as in families described in the literature before, generally show a severe, early-onset form of DCM. (Neth Heart J 2010;18:478-85.).

Entities:  

Keywords:  Cardiomyopathy; Dilated; Genetics ; Troponin T

Year:  2010        PMID: 20978592      PMCID: PMC2954300          DOI: 10.1007/BF03091819

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  33 in total

1.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

Authors:  M Kamisago; S D Sharma; S R DePalma; S Solomon; P Sharma; B McDonough; L Smoot; M P Mullen; P K Woolf; E D Wigle; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

3.  Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.

Authors:  Steffen Daehmlow; Jeanette Erdmann; Tanja Knueppel; Christoph Gille; Cornelius Froemmel; Manfred Hummel; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  Biochem Biophys Res Commun       Date:  2002-10-18       Impact factor: 3.575

4.  Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE.

Authors:  Raphael Zeller; Boris T Ivandic; Philipp Ehlermann; Oliver Mücke; Christian Zugck; Andrew Remppis; Evangelos Giannitsis; Hugo A Katus; Dieter Weichenhan
Journal:  J Mol Med (Berl)       Date:  2006-05-20       Impact factor: 4.599

5.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

Authors:  J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

6.  Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity.

Authors:  Christopher B Stefanelli; Amnon Rosenthal; Andrei B Borisov; Gregory J Ensing; Mark W Russell
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

7.  Mutations in sarcomere protein genes in left ventricular noncompaction.

Authors:  Sabine Klaassen; Susanne Probst; Erwin Oechslin; Brenda Gerull; Gregor Krings; Pia Schuler; Matthias Greutmann; David Hürlimann; Mustafa Yegitbasi; Lucia Pons; Michael Gramlich; Jörg-Detlef Drenckhahn; Arnd Heuser; Felix Berger; Rolf Jenni; Ludwig Thierfelder
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

Review 8.  DNA analysis in inherited cardiomyopathies: current status and clinical relevance.

Authors:  Karin Y van Spaendonck-Zwarts; Maarten P van den Berg; J Peter van Tintelen
Journal:  Pacing Clin Electrophysiol       Date:  2008-02       Impact factor: 1.976

9.  Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology.

Authors:  S C Menon; V V Michels; P A Pellikka; J D Ballew; M L Karst; K J Herron; S M Nelson; R J Rodeheffer; T M Olson
Journal:  Clin Genet       Date:  2008-07-21       Impact factor: 4.438

10.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

View more
  6 in total

1.  Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.

Authors:  E Otten; R H Lekanne Dit Deprez; M M Weiss; M van Slegtenhorst; M Joosten; J J van der Smagt; N de Jonge; W S Kerstjens-Frederikse; M T R Roofthooft; A H M M Balk; M P van den Berg; J S Ruiter; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Interplay between the effects of a Protein Kinase C phosphomimic (T204E) and a dilated cardiomyopathy mutation (K211Δ or R206W) in rat cardiac troponin T blunts the magnitude of muscle length-mediated crossbridge recruitment against the β-myosin heavy chain background.

Authors:  John Jeshurun Michael; Sampath K Gollapudi; Murali Chandra
Journal:  J Muscle Res Cell Motil       Date:  2016-07-13       Impact factor: 2.698

3.  Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy.

Authors:  Takeshi Suzuki; Takao Shioya; Takashi Murayama; Masami Sugihara; Fuminori Odagiri; Yuji Nakazato; Hiroto Nishizawa; Akihito Chugun; Takashi Sakurai; Hiroyuki Daida; Sachio Morimoto; Nagomi Kurebayashi
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

4.  Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.

Authors:  Mingmin Li; Shuang Xia; Lan Xu; Hong Tan; Junqing Yang; Zejia Wu; Xuyu He; Liwen Li
Journal:  J Transl Med       Date:  2021-05-03       Impact factor: 5.531

5.  Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice.

Authors:  Fuminori Odagiri; Hana Inoue; Masami Sugihara; Takeshi Suzuki; Takashi Murayama; Takao Shioya; Masato Konishi; Yuji Nakazato; Hiroyuki Daida; Takashi Sakurai; Sachio Morimoto; Nagomi Kurebayashi
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

6.  Genotype-specific pathogenic effects in human dilated cardiomyopathy.

Authors:  Ilse A E Bollen; Maike Schuldt; Magdalena Harakalova; Aryan Vink; Folkert W Asselbergs; Jose R Pinto; Martina Krüger; Diederik W D Kuster; Jolanda van der Velden
Journal:  J Physiol       Date:  2017-06-01       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.